About Event
Join the Only Event Dedicated to Optimizing ADC Process Development & Accelerating Manufacturing to Stay Ahead of Shortening Timeframes
As the ADC industry grows more competitive and manufacturing timelines get shorter, don’t let your processes hold you back.
Returning for a second year, the ADC Process Development Summit boasts three jam-packed days of novel presentations, roundtable discussions and interactive workshops, all tailored to provide cutting-edge insights to help you enhance the yield, purity and homogeneity of your ADC processes.
Pioneers of the field will be navigating CQA setting and regulatory control strategies, unlocking maximum conjugation yield to decrease heterogeneity, optimizing purification processes to increase process robustness, and evaluating how to handle deviation challenges in ADC manufacturing.
Join a highly focused audience from the likes of AstraZeneca, Bristol Myers Squibb, Pfizer, Exelixis, Johnson & Johnson, Gilead and AbbVie for in-depth discussions that will empower you with practical take-home lessons to revolutionize your ADC manufacturing process.
Achieve your goals for 2024:
Minimize unit operations and costs by perfecting tangential flow filtration with Pfizer and dive into Gilead’s cutting-edge non-chromatographic purification techniques.
Propel your process development scale-up with Johnson & Johnson, fine-tuning specifications, streamlining processes, and prepping for seamless outsourcing.
Accelerate drug product development with AstraZeneca and Exelixis, unlocking advanced stability insights and ensuring process robustness for unmatched success.
Who Will You Meet?
The 2nd ADC Process Development Summit is bringing together a community of industry experts, to facilitate an in-depth discussion, purpose built for those working in process development, conjugation, purification, control, CMC and engineering.
Aimed at both Directors overseeing the entire process and manufacturing lifecycle all the way through to hands-on scientists, this is the only conference that provides an intimate forum for technical and strategic discussion for those that prioritize optimizing their ADC manufacturing processes.
With practical applicability at the heart of the summit, leave ready to impact your day-to-day roles and optimize both your current and future process development.
What This Year's Speakers Are Excited About:
“I’m thrilled about ADCs and their promising future. These drugs have significantly benefited patients, even when other cancer therapies might not have been safe. Regarding the summit, the focused group setting provides an excellent opportunity to connect with remarkable individuals and learn from their experiences.”
“ADC therapeutics could be a way to tackle critical unmet need in Oncology. The recent approvals is a testimony to this end. ADC development and manufacturing however present new challenges and it is fascinating to be able to tackle and solve the associated issues”
“The ADC Process Development Summit is an exciting opportunity to share insights and have great discussions with colleagues related to our shared interest of antibody-drug conjugates.”
